美鼎生物(VIVO)

莫芒旎2022-08-14 09:00

$美鼎生物(VIVO)$ 收购什么时候完成？瞎买了230120的35看涨期权，是不是打水漂了？查看全文

用户28964502982022-07-08 16:40

$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文

牛唐2022-07-08 15:08

韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文

持股变动声明

$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-22-002347  Size: 6 KB 网页链接

当期报告

$美鼎生物(VIVO)$ 8-K Current report, items 5.02 and 5.07 Accession Number: 0001193125-22-019710  Act: 34  Size: 188 KB 网页链接

超过5%股东持股披露「修订」

$美鼎生物(VIVO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-002057  Act: 34  Size: 13 KB 网页链接

超过5%股东持股披露「修订」

$美鼎生物(VIVO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-000579  Act: 34  Size: 13 KB 网页链接

超过5%股东持股披露

$美鼎生物(VIVO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000906304-22-000037  Act: 34  Size: 11 KB 网页链接

$美鼎生物(VIVO)$ 内部交易: 2022-01-12,Director,PHILLIPS DAVID ,期权,7500普通股, $18.54

持股变动声明

$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-22-001477  Size: 7 KB 网页链接

首次持股声明

$美鼎生物(VIVO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001567619-22-000002  Size: 14 KB 网页链接

持股变动声明

$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-031730  Size: 4 KB 网页链接

持股变动声明

$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-031731  Size: 4 KB 网页链接